Page 53 - 《中国药房》2024年22期
P. 53

Iβ、IL-18水平均显著升高,可见该抑制剂逆转了石淋清                       [10]  CHEUNGPASITPORN W,ROSSETTI S,FRIEND K,et
          颗粒激活 SIRT1 蛋白所带来的有利作用。以上研究结                             al. Treatment effect,adherence,and safety of high fluid in‐
          果表明,石淋清颗粒可通过调控SIRT1/NF-κB/NLRP3信                        take  for  the  prevention  of  incident  and  recurrent  kidney
          号通路来发挥抗炎作用,从而减轻模型大鼠的肾损伤,                                stones:a  systematic  review  and  meta-analysis[J].  J
                                                                  Nephrol,2016,29(2):211-219.
          抑制草酸钙肾结石的形成。
                                                             [11]  王振,杨秀书,陈卫红,等. 川芎嗪通过抑制NLRP3炎性
              综上所述,石淋清颗粒可抑制大鼠草酸钙肾结石的
          形成,降低炎症指标水平;其机制可能与上调 SIRT 1 蛋                           小体活化对肾结石大鼠肾脏的保护作用[J]. 中成药,
                                                                  2023,45(11):3789-3792.
          白表达,下调NF-κB、NLRP3蛋白表达有关。                                WANG Z,YANG X S,CHEN W H,et al. Protective ef‐
          参考文献                                                    fect of ligustrazine on kidney of kidney calculi rats by in‐
          [ 1 ]  JALAL S M,ALSULTAN A A,ALOTAIBI H H,et al. Ef‐   hibiting activation of inflammatory corpuscles of NLRP3
              fect  of  Phaseolus  vulgaris  on  urinary  biochemical  para-  [J]. Chin Tradit Pat Med,2023,45(11):3789-3792.
              meters among patients with kidney stones in Saudi Arabia  [12]  KHAN  S  R,PEARLE  M  S,ROBERTSON  W  G,et  al.
              [J]. Nutrients,2020,12(11):3346.                    Kidney stones[J]. Nat Rev Dis Primers,2016,2:16008.
          [ 2 ]  MALINE G E,GOLDFARB D S. Climate change and kid‐  [13]  许悦贤,郝宗耀. 泌尿系结石动物模型的最新进展[J]. 临
              ney  stones[J].  Curr  Opin  Nephrol  Hypertens,2024,33  床泌尿外科杂志,2022,37(7):559-563.
              (1):89-96.                                          XU Y X,HAO Z Y. Recent advances in animal models of
          [ 3 ]  THONGBOONKERD V. Proteomics of crystal-cell inter-  urinary calculi[J]. J Clin Urol,2022,37(7):559-563.
              actions:a model for kidney stone research[J]. Cells,2019,  [14]  柯井卫,朱永生,唐海,等. 棱术排石颗粒对肾草酸钙结
              8(9):1076.                                          石作用机制的研究[J]. 中国比较医学杂志,2021,31(8):
          [ 4 ]  ZHAO C Y,ZHAO W. NLRP3 inflammasome:a key player   82-87.
              in antiviral responses[J]. Front Immunol,2020,11:211.  KE J W,ZHU Y S,TANG H,et al. Study of the mecha‐
          [ 5 ]  SUN  H  J,XIONG  S  P,CAO  X,et  al.  Polysulfide-  nism whereby Lengzhupaishi(rixolipite)granules prevent
              mediated  sulfhydration  of  SIRT1  prevents  diabetic  ne‐  renal calcium oxalate stones[J]. Chin J Comp Med,2021,
              phropathy by suppressing phosphorylation and acetylation   31(8):82-87.
              of p65 NF-κB and STAT3[J]. Redox Biol,2021,38:101813.  [15]  齐士勇,徐勇. NLRP3炎症小体与草酸钙肾结石形成的
          [ 6 ]  陈曙辉,任毅轩,曹继刚. 基于网络药理学探析金钱草作                       研究进展[J]. 医学综述,2021,27(19):3749-3754.
              为石淋要药治疗肾结石的作用机制研究[J]. 中国中西医                         QI S Y,XU Y. Research progress in relationship between
              结合肾病杂志,2021,22(4):340-344,377.                      NLRP3  inflammasome  and  formation  of  calcium  oxalate
              CHEN S H,REN Y X,CAO J G. Study on the mechanism    kidney stone[J]. Med Recapitul,2021,27(19):3749-3754.
              of Lysimachia christinae as a essential medicine for treating   [16]  PELLEGRINI C,FORNAI M,ANTONIOLI L,et al. Phy‐
              kidney calculus based on network pharmacology[J]. Chin J   tochemicals  as  novel  therapeutic  strategies  for  NLRP3
              Integr Tradit West Nephrol,2021,22(4):340-344,377.  inflammasome-related  neurological,metabolic,and  in‐
          [ 7 ]  岑庚钰,蒙小丽,梁远芳,等. 海金沙化学成分和药理作                       flammatory diseases[J]. Int J Mol Sci,2019,20(12):2876.
              用研究概况[J]. 中国民族民间医药,2018,27(14):48-50.          [17]  SWANSON K V,DENG M,TING J P Y. The NLRP3 in‐
              CEN G Y,MENG X L,LIANG Y F,et al. Study on the      flammasome:molecular activation and regulation to thera‐
              chemical composition and pharmacological activity of the   peutics[J]. Nat Rev Immunol,2019,19(8):477-489.
              Lygodium  japonicum[J].  Chin  J  Ethnomed  Ethnophar‐  [18]  CAI H,ZHANG J H,XU H,et al. ALOX5 drives the py‐
              macy,2018,27(14):48-50.                             roptosis of CD4  T cells and tissue inflammation in rheu‐
                                                                              +
          [ 8 ]  毛鑫,姚荣妹,鲍岩岩,等 . 王不留行多糖通过抑制                        matoid arthritis[J]. Sci Signal,2024,17(825):eadh1178.
              NLRP3 炎性小体通路改善尿路感染所致膀胱损伤[J].                   [19]  HONG Q,ZHANG L,DAS B,et al. Increased podocyte
              中国中药杂志,2021,46(13):3388-3393.                       sirtuin-1 function attenuates diabetic kidney injury[J].
              MAO X,YAO R M,BAO Y Y,et al. Effect of polysaccha‐  Kidney Int,2018,93(6):1330-1343.
              rides  from  seeds  of Vaccaria  segetalis  in  alleviating  uri‐  [20]  田河,王志龙,张智慧,等 . 白藜芦醇通过靶向 SIRT1 激
              nary  tract  infection  induced  bladder  injury  by  inhibiting   活Keap1-Nrf2-HO-1途径发挥对草酸钙肾结石形成的调
              NLRP3  inflammasome[J].  China  J  Chin  Mater  Med,  控作用[J]. 中国比较医学杂志,2020,30(2):77-83.
              2021,46(13):3388-3393.                              TIAN  H,WANG  Z  L,ZHANG  Z  H,et  al.  Resveratrol
          [ 9 ]  韩晗. 基于p38 MAPK信号通路探讨排石冲剂干预草酸                     plays a regulatory role in the formation of calcium oxalate
              钙结石形成的机制[D]. 武汉:湖北中医药大学,2019.                       kidney stones by targeting SIRT1 to activate the Keap1-Nrf2-
              HAN H. Discussion on the mechanism of Paishi granule’s   HO-1 pathway[J]. Chin J Comp Med,2020,30(2):77-83.
              intervention on calcium oxalate stone formation based on      (收稿日期:2024-03-26  修回日期:2024-07-30)
              p38 MAPK signal pathway[D]. Wuhan:Hubei University                                  (编辑:张元媛)
              of Chinese Medicine,2019.



          中国药房  2024年第35卷第22期                                              China Pharmacy  2024 Vol. 35  No. 22    · 2755 ·
   48   49   50   51   52   53   54   55   56   57   58